LNAI
Lunai Bioworks Inc.

3,365
Mkt Cap
$20.75M
Volume
156,404.00
52W High
$14.00
52W Low
$0.81
PE Ratio
-0.11
LNAI Fundamentals
Price
$0.8817
Prev Close
$0.8854
Open
$0.89
50D MA
$1.09
Beta
1.25
Avg. Volume
12.31M
EPS (Annual)
-$10.78
P/B
-1.57
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market
Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market Lunai Bioworks Identifies Three...
PR Newswire·23d ago
News Placeholder
LNAI Stock Soars Pre-Market After Immune Cell Therapy Gains Licensee Interest
The cell therapy, Dendritic Cell Combination Therapy (DCCT), achieved complete regression of both primary and metastatic pancreatic tumors with no recurrence in humanized preclinical models.
Stocktwits·1mo ago
News Placeholder
Top Biotech Stocks To Follow Now - November 5th
Danaher, Vertex Pharmaceuticals, Recursion Pharmaceuticals, Moderna, and Lunai Bioworks are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are...
MarketBeat·2mo ago
<
...
1
>

Latest LNAI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.